(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Somalia set for 'historic' first offshore oil drilling - 2The most effective method to Go Down Abundance through Ages with Disc Rates
- 3The Best Traditional Music Arrangers in History
- 4From Specialist to Proficient Picture taker: Individual Triumphs
- 5Toyota Reports 2.3% Sales Drop as China Weakness Deepens
- Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
- Bavarian leader questions Germany's Eurovision participation
- Manual for Tracking down Spending plan Agreeable Travel Objections
- A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- Los Angeles County sees significant uptick in norovirus cases, officials say
- NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth?
- The most effective method to Look at Medical caretaker Compensations Across Various Clinics
